BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Y, Xie F, Kong MC, Lee LH, Ng HJ, Ko Y. Patient-reported health preferences of anticoagulant-related outcomes. J Thromb Thrombolysis 2015;40:268-73. [PMID: 25875937 DOI: 10.1007/s11239-015-1191-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Zeitler EP, Eapen ZJ. Anticoagulation in Heart Failure: a Review. J Atr Fibrillation 2015;8:1250. [PMID: 27957180 DOI: 10.4022/jafib.1250] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
2 Wilke T, Bauer S, Mueller S, Kohlmann T, Bauersachs R. Patient Preferences for Oral Anticoagulation Therapy in Atrial Fibrillation: A Systematic Literature Review. Patient 2017;10:17-37. [PMID: 27461276 DOI: 10.1007/s40271-016-0185-9] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 10.2] [Reference Citation Analysis]
3 Rajan N, Boye KS, Gibbs M, Lee YJ, Davey P, Ball M, Babineaux SM. Utilities for Type 2 Diabetes Treatment-Related Attributes in a South Korean and Taiwanese Population. Value in Health Regional Issues 2016;9:67-71. [DOI: 10.1016/j.vhri.2015.11.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
4 Gorog DA, Gue YX, Chao TF, Fauchier L, Ferreiro JL, Huber K, Konstantinidis SV, Lane DA, Marin F, Oldgren J, Potpara T, Roldan V, Rubboli A, Sibbing D, Tse HF, Vilahur G, Lip GYH. Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society. Europace 2022:euac020. [PMID: 35323922 DOI: 10.1093/europace/euac020] [Reference Citation Analysis]
5 Afzal SK, Hasan SS, Babar ZU. A systematic review of patient-reported outcomes associated with the use of direct-acting oral anticoagulants. Br J Clin Pharmacol 2019;85:2652-67. [PMID: 31077431 DOI: 10.1111/bcp.13985] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
6 Wilke T, Bauer S, Mueller S, Kohlmann T, Bauersachs R. Patient Preferences for Oral Anticoagulation Therapy in Atrial Fibrillation: A Systematic Literature Review. Patient 2017;10:17-37. [PMID: 27461276 DOI: 10.1007/s40271-016-0185-9] [Cited by in Crossref: 54] [Cited by in F6Publishing: 1] [Article Influence: 9.0] [Reference Citation Analysis]
7 Blieden Betts M, Gandra SR, Cheng L, Szatkowski A, Toth PP. Differences in utility elicitation methods in cardiovascular disease: a systematic review. Journal of Medical Economics 2018;21:74-84. [DOI: 10.1080/13696998.2017.1379410] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]